These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12872351)

  • 1. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.
    Nucci M; Anaissie EJ; Queiroz-Telles F; Martins CA; Trabasso P; Solza C; Mangini C; Simões BP; Colombo AL; Vaz J; Levy CE; Costa S; Moreira VA; Oliveira JS; Paraguay N; Duboc G; Voltarelli JC; Maiolino A; Pasquini R; Souza CA
    Cancer; 2003 Jul; 98(2):315-9. PubMed ID: 12872351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.
    Campo M; Lewis RE; Kontoyiannis DP
    J Infect; 2010 May; 60(5):331-7. PubMed ID: 20138081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
    Chamilos G; Lewis RE; Kontoyiannis DP
    Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program.
    Pagano L; Girmenia C; Mele L; Ricci P; Tosti ME; Nosari A; Buelli M; Picardi M; Allione B; Corvatta L; D'Antonio D; Montillo M; Melillo L; Chierichini A; Cenacchi A; Tonso A; Cudillo L; Candoni A; Savignano C; Bonini A; Martino P; Del Favero A; ;
    Haematologica; 2001 Aug; 86(8):862-70. PubMed ID: 11522544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal Trichosporon fungemia in patients with hematologic malignancies.
    Suzuki K; Nakase K; Kyo T; Kohara T; Sugawara Y; Shibazaki T; Oka K; Tsukada T; Katayama N
    Eur J Haematol; 2010 May; 84(5):441-7. PubMed ID: 20059528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
    Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Ho DY; Lee JD; Rosso F; Montoya JG
    Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients.
    Rizk SS; Kraus DH; Gerresheim G; Mudan S
    Ear Nose Throat J; 2000 Apr; 79(4):278-80, 282, 284-5. PubMed ID: 10786391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S; Thibbadee C; Santanirand P
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
    Raad II; Hachem RY; Herbrecht R; Graybill JR; Hare R; Corcoran G; Kontoyiannis DP
    Clin Infect Dis; 2006 May; 42(10):1398-403. PubMed ID: 16619151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
    Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
    J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Perfect JR
    Clin Infect Dis; 2005 May; 40 Suppl 6():S401-8. PubMed ID: 15809926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review.
    Kumashi PR; Safdar A; Chamilos G; Chemaly RF; Raad II; Kontoyiannis DP
    Clin Microbiol Infect; 2006 Jul; 12(7):621-6. PubMed ID: 16774557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies.
    Kataoka-Nishimura S; Akiyama H; Saku K; Kashiwa M; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
    Cancer; 1998 Feb; 82(3):484-7. PubMed ID: 9452265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO.
    Hennequin C; Lavarde V; Poirot JL; Rabodonirina M; Datry A; Aractingi S; Dupouy-Camet J; Caillot D; Grange F; Kures L; Morin O; Lebeau B; Bretagne S; Guigen C; Basset D; Grillot R
    J Med Vet Mycol; 1997; 35(2):107-14. PubMed ID: 9147270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.